| 000 | 01904 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516182141.0 | ||
| 264 | 0 | _c20140715 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a1941-2703 | ||
| 024 | 7 |
_a10.1089/jamp.2013.1049 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSwaminathan, Janani | |
| 245 | 0 | 0 |
_aEncapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin. _h[electronic resource] |
| 260 |
_bJournal of aerosol medicine and pulmonary drug delivery _cFeb 2014 |
||
| 300 |
_a1-11 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xpathology |
| 650 | 0 | 4 | _aBuffers |
| 650 | 0 | 4 |
_aCalcitonin _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 |
_aLung _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aStress, Mechanical |
| 650 | 0 | 4 | _aSurface Properties |
| 700 | 1 | _aGobbo, Oliviero L | |
| 700 | 1 | _aTewes, Frederic | |
| 700 | 1 | _aHealy, Anne Marie | |
| 700 | 1 | _aEhrhardt, Carsten | |
| 773 | 0 |
_tJournal of aerosol medicine and pulmonary drug delivery _gvol. 27 _gno. 1 _gp. 1-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/jamp.2013.1049 _zAvailable from publisher's website |
| 999 |
_c23285023 _d23285023 |
||